Senior Principal Scientist, Oncology Radioligand Therapies - Fr.122'500 - Fr.227'500 A Year
SwiftCruit
- Basel
- Vollzeit
- Biotechnologie
- 125000 - 227500 € / Jahr (geschätzt)
Posted 23 Stunden ago
4118 Jobs
SwiftCruit
BeiGene
Novartis
CRISPR Therapeutics
Lonza
Lonza
Lonza
Novartis
Swiss Bioscience
Swiss Bioscience